Science and Research

[Sirolimus for LAM - A New MILEStone Reached?]

  • Kreuter, M.
  • Wirtz, H.

Keywords

  • Antibiotics, Antineoplastic/*therapeutic use
  • Humans
  • Immunosuppressive Agents/*therapeutic use
  • Lipopolysaccharides
  • Lymphangioleiomyomatosis/*drug therapy
  • Sirolimus/*therapeutic use
  • Vortragshonorare von Pfizer erhalten.
Publication details
DOI: 10.1055/a-0802-3633
Journal: Pneumologie
Pages: 22-23 
Number: 1
Work Type: Original
Location: TLRC
Disease Area: DPLD
Partner / Member: Thorax
Access-Number: 30541159
See publication on PubMed

DZL Engagements

chevron-down